
Company profile
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products.
At the end of 2024, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world.
Net sales are distributed geographically as follows: Europe (51%), North America (38.3%) and other (10.7%).
Source:
Cofisem
-
Last Update:
27 Feb 2025
Key Executives
Chairman and Chief Executive Officer | Gilles G. Martin | ||||
Administrative & Finance Director | Laurent Lebras | ||||
Chief Operating Officer | Christian Wurst | ||||
Source: Cofisem - Last Update: 27 Feb 2025 |
Key figures
Millenium | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Net sales | 6.951.000 | 6.514.600 | 6.712.100 | 6.717.700 | 5.438.800 |
Income from ordinary activities | 6.951.000 | 6.514.600 | 6.712.100 | 6.717.700 | 5.438.800 |
Operating income | 680.600 | 529.900 | 916.000 | 1.258.200 | 800.300 |
Cost of financial indebtedness net | 144.200 | 120.800 | 88.600 | 80.800 | 95.100 |
Equity-accounted companies contribution to income | 1.000 | 400 | 900 | 2.000 | 1.700 |
Net profit from discontinued activities | 200 | 900 | |||
Net income | 405.500 | 307.700 | 605.800 | 783.000 | 540.500 |
Net income (Group share) | 406.400 | 310.200 | 610.200 | 782.600 | 539.500 |
Fiscal year end | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
Currency & Unit | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands | EUR - thousands |
Account Standards | IFRS | IFRS | IFRS | IFRS | IFRS |
Source: Cofisem - Last Update: 27 Feb 2025 |
Shareholder information
Address
Eurofins Scientific SE
23 Val Fleuri
LU-1526
Luxemburg
Luxembourg
Phone number:
+352 261 85 320
Fax:
+352 261 85 331
Source:
Cofisem
-
Last Update:
27 Feb 2025